NCT06441526View on ClinicalTrials.gov

Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design

PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

September 14, 2013

Primary Completion Date

December 7, 2019

Study Completion Date

June 7, 2021

Conditions
Perianal FistulaCrohn Disease
Interventions
DRUG

anti-tumour necrosis factor α antibodies

Biological drug

PROCEDURE

Advancement plasty

Surgical closure of the internal opening

Trial Locations (1)

1105AZ

Amsterdam UMC, Amsterdam-Zuidoost

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT06441526 - Surgical Closure vs Anti-TNF in the Treatment of Perianal Fistulas in Crohn's Disease (PISA-II): a Comprehensive Cohort Design | Biotech Hunter | Biotech Hunter